Search filters

List of works by Kieron Dunleavy

A new prognostic score for AIDS-related lymphomas in the rituximab-era

scientific article

A novel role for IL-22R1 as a driver of inflammation

scientific article

A prospective study of mediastinal gray-zone lymphoma

scientific article

Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications

scientific article published on July 2007

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

scientific article

Circulating serum free light chains as predictive markers of AIDS-related lymphoma

scientific article

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

scientific article published on April 2015

Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.

scientific article

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

scientific article

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

scientific article

Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies ⬇️

scientific article published on February 6, 2012

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

scientific article published on 01 December 2018

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma

scientific article

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

scientific article published on 10 May 2018

Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

scientific article published on September 2012

Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.

scientific article

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

scientific article published on 9 September 2004

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

scientific article published on 10 May 2017

Low-intensity therapy in adults with Burkitt's lymphoma.

scientific article

Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes

scientific article

Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations

scientific article

MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.

scientific article published on 22 June 2017

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

scientific article published on 26 May 2020

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity ⬇️

scientific article published on November 18, 2010

New Strategies in Peripheral T-Cell Lymphoma: Understanding Tumor Biology and Developing Novel Therapies ⬇️

scientific article published on December 1, 2010

Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression

scientific article

Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.

scientific article published on 12 July 2011

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

scientific article

Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma

scientific article published on 30 October 2015

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

scientific article

Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?

scientific article published in September 2011

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

scientific article

The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma

scientific article

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma

scientific article published on 21 August 2005

Paulina is supported by:

About Paulina

Help